microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer

作者: YEUNPO CHIANG , YONGXI SONG , ZHENNING WANG , ZHUANGKAI LIU , PENG GAO

DOI: 10.3892/ETM.2011.436

关键词:

摘要: microRNAs (miRNAs) are small, non-coding RNAs of endogenous origin. They have been increasingly shown to aberrant expression in a number tumor types. miR-192, -194 and -215 not comprehensively investigated using large cases colorectal cancer (CRC). We extracted total RNA from 107 CRC tissues three cell lines. Following polyadenylation reverse transcription, the levels were determined for evaluation association between clinicopathological characteristics by quantitative real-time polymerase chain reaction (real-time PCR) method. Finally, we studied impact miR-194 on proliferation HCT-116 cells MTT assay. significantly downregulated (all p<0.001, paired t-test) lines p<0.05) compared non-tumor counterparts. Moreover, demonstrated be associated with increased sizes (p=0.027, p=0.018, p=0.027, respectively; Mann-Whitney U test). Also, there marked correlations among these miRNAs Pearson's regression analysis). Furthermore, found that overexpression could inhibit HTC-116 cells. may important biological markers as suppressors carcinogenesis CRC.

参考文章(33)
Lauri A. Aaltonen, Stanley R. Hamilton, Pathology and genetics of tumours of the digestive system IARC Press. ,(2000)
Aurora Esquela-Kerscher, Frank J. Slack, Oncomirs — microRNAs with a role in cancer Nature Reviews Cancer. ,vol. 6, pp. 259- 269 ,(2006) , 10.1038/NRC1840
Lee P. Lim, Nelson C. Lau, Philip Garrett-Engele, Andrew Grimson, Janell M. Schelter, John Castle, David P. Bartel, Peter S. Linsley, Jason M. Johnson, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature. ,vol. 433, pp. 769- 773 ,(2005) , 10.1038/NATURE03315
Yue Chen, Yongxi Song, Zhenning Wang, Zhenyu Yue, Huimian Xu, Chengzhong Xing, Zhuangkai Liu, Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance Journal of Gastrointestinal Surgery. ,vol. 14, pp. 1170- 1179 ,(2010) , 10.1007/S11605-010-1202-2
C. J. Braun, X. Zhang, I. Savelyeva, S. Wolff, U. M. Moll, T. Schepeler, T. F. Orntoft, C. L. Andersen, M. Dobbelstein, p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest Cancer Research. ,vol. 68, pp. 10094- 10104 ,(2008) , 10.1158/0008-5472.CAN-08-1569
Raffaele Baffa, Matteo Fassan, Stefano Volinia, Brian O'Hara, Chang‐Gong Liu, Juan P Palazzo, Marina Gardiman, Massimo Rugge, Leonard G Gomella, Carlo M Croce, Anne Rosenberg, None, MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. The Journal of Pathology. ,vol. 219, pp. 214- 221 ,(2009) , 10.1002/PATH.2586
George A. Calin, Carlo M. Croce, MicroRNA signatures in human cancers Nature Reviews Cancer. ,vol. 6, pp. 857- 866 ,(2006) , 10.1038/NRC1997
Junhao Gui, Yaping Tian, Xinyu Wen, Wenhui Zhang, Pengjun Zhang, Jing Gao, Wei Run, Liyuan Tian, Xingwang Jia, Yanhong Gao, Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clinical Science. ,vol. 120, pp. 183- 193 ,(2011) , 10.1042/CS20100297
Nozomu Yanaihara, Natasha Caplen, Elise Bowman, Masahiro Seike, Kensuke Kumamoto, Ming Yi, Robert M. Stephens, Aikou Okamoto, Jun Yokota, Tadao Tanaka, George Adrian Calin, Chang-Gong Liu, Carlo M. Croce, Curtis C. Harris, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell. ,vol. 9, pp. 189- 198 ,(2006) , 10.1016/J.CCR.2006.01.025